BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2146884)

  • 1. Reconstitution of solubilized V1 vasopressin receptors of human platelets.
    Thibonnier M; Bayer AL; Simonson MS; Snajdar RM
    Am J Physiol; 1990 Nov; 259(5 Pt 1):E751-6. PubMed ID: 2146884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells.
    Gopalakrishnan V; Xu YJ; Sulakhe PV; Triggle CR; McNeill JR
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1927-36. PubMed ID: 1836312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human platelet vasopressin receptors.
    Thibonnier M; Roberts JM
    J Clin Invest; 1985 Nov; 76(5):1857-64. PubMed ID: 2997293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells.
    Thibonnier M; Bayer AL; Simonson MS; Kester M
    Endocrinology; 1991 Dec; 129(6):2845-56. PubMed ID: 1659517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin increases cytosolic free [Ca2+] in the neonatal rat cardiomyocyte. Evidence for V1 subtype receptors.
    Xu YJ; Gopalakrishnan V
    Circ Res; 1991 Jul; 69(1):239-45. PubMed ID: 2054937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets.
    Inaba K; Umeda Y; Yamane Y; Urakami M; Inada M
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):377-86. PubMed ID: 2978018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein coupling of human platelet V1 vascular vasopressin receptors.
    Thibonnier M; Goraya T; Berti-Mattera L
    Am J Physiol; 1993 May; 264(5 Pt 1):C1336-44. PubMed ID: 8498489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
    Stassen FL; Heckman G; Schmidt D; Nambi P; Aiyar N; Landvatter S; Crooke ST
    Mol Pharmacol; 1987 Mar; 31(3):267-72. PubMed ID: 2951585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization of human platelet vasopressin receptors.
    Thibonnier M
    Life Sci; 1987 Feb; 40(5):439-45. PubMed ID: 3807642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
    Soloff MS; Fernström MA; Fernström MJ
    Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C.
    Aiyar N; Bennett CF; Nambi P; Valinski W; Angioli M; Minnich M; Crooke ST
    Biochem J; 1989 Jul; 261(1):63-70. PubMed ID: 2549966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
    Aiyar N; Nambi P; Stassen F; Crooke ST
    Mol Pharmacol; 1987 Jul; 32(1):34-6. PubMed ID: 2955212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amiloride analogues on AVP binding and activation of V1-receptor-expressing cells.
    Thibonnier M; Bayer AL; Simonson MS; Douglas JG
    Am J Physiol; 1992 Jan; 262(1 Pt 1):E76-86. PubMed ID: 1733254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a specific, high affinity [3H]arginine8 vasopressin-binding site on liver microsomes from different strains of rat and the role of magnesium.
    Gopalakrishnan V; Triggle CR; Sulakhe PV; McNeill JR
    Endocrinology; 1986 Mar; 118(3):990-7. PubMed ID: 3004905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonizes the magnesium-induced high affinity state of the hepatic vasopressin receptor for the agonist interaction.
    Wang H; Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Br J Pharmacol; 1990 May; 100(1):5-10. PubMed ID: 2372661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear V1-vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling.
    Thibonnier M; Bayer AL; Madhun Z
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E906-13. PubMed ID: 8279546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.
    Maggi M; Malozowski S; Kassis S; Guardabasso V; Rodbard D
    Endocrinology; 1987 Mar; 120(3):986-94. PubMed ID: 3026794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.